info@imoveflu.org

Login

Scientific communications

I-MOVE scientific communications

Below is a non-exhaustive list of I-MOVE scientific communications, both at study site and at pooled level. Please see also the I-MOVE protocols and the published articles page. If you would like to let us know about an I-MOVE scientific communication, please contact us.

Oral presentations

  • Kissling E. Integrating genetic sequencing information into vaccine effectiveness analyses. ECDC SARI surveillance meeting.19 May 2021
  • Dijkstra F, et al. Deaths, hospitalisations and GP visits attributable to influenza infection averted by the influenza vaccination programme in the Netherlands among persons aged 65 and older, seasons 2015/16–2017/18. ESCAIDE Conference, Stockholm, 27–29 November 2019.
  • Machado A, et al. Impact of national influenza vaccination strategy among the high-risk Portuguese population in severe influenza outcomes. ESCAIDE Conference, Stockholm, 27–29 November 2019.
  • Kissling E, et al. 2018/19 primary care influenza vaccine effectiveness against influenza A(H3N2) in Europe: no effectiveness among 15–64
    year olds. ESCAIDE Conference, Stockholm, 27–29 November 2019.
  • Kissling E, et al. Vaccine effectiveness against influenza A(H1N1)pdm09 and A(H3N2): Results from the 2018/19 European I-MOVE primary care multicentre study. ESCAIDE Conference, Stockholm, 27–29 November 2019.
  • Rose A, et al. Vaccine effectiveness against influenza A(H3N2) and A(H1N1) in older adults and the effects of age-group and statins: Results from the I-MOVE hospital network, 2018–19. ESCAIDE Conference, Stockholm, 27–29 November 2019.
  • Lazăr M, Cherciu CM, Mihai ME, Popescu R, Popovici O. Genetic characterization of influenza virus circulating in Romania during the 2018/2019 season (Caracterizarea genetică a virusurilor gripale identificate în perioada sezonului 2018/2019 în România), 12th N  National Conference for Romanian Microbiology and Epidemiology, Bucharest, Romania, 14-16 november 2019.
  • Cherciu CM, Mihai ME, Lazăr M. Antigenically characterization of influenza virus isolates in 2015-2019 period in Romania, 12th National Conference for Romanian Microbiology and Epidemiology, Bucharest, Romania, 14-16 november 2019.
  • Lazăr M, Cherciu CM, Pascu C, Mihai ME, Popescu R, Popovici O, Pistol A. Integrating whole-genome sequencing data to provide insights into the epidemiology of seasonal influenza viruses in Romania, 15th Edition of The Scientific Days of the National Institute for Infectious Diseases “Prof.Dr.Matei Balș”, National Congress with internaționl attendance, Bucharest, Romania, 30 october-1 november 2019.
  • Mihai ME, Cherciu CM, Mihaescu G, Lazăr M. Phenotipic method for determining the sensitivity of influenza virus to antivirals – The Annual International Conference of the Romanian Society of Biochemistry and Molecular Biology, Iași, Romania, 26-27th September, 2019.
  • Martínez-Baz I, Emborg HD, Baum U, Casado I, Svanström H, Jokinen J, et al. Influenza vaccine effectiveness against hospitalizations using cohort and test-negative case-control designs. XXXVI Reunión científica de la SEE, Lisboa 11-14 septiembre 2018.
  • Casado I, Martínez-Baz I, Navascués A, Pérez-García A, Aguinaga A, Ezpeleta G, et al. Efectividad de la vacuna antigripal trivalente en una temporada con predominio de gripe B de linaje discordante. [Influenza vaccine effectiveness in a season dominated by lineage mismatched influenza B]. XXXVI Reunión científica de la SEE, Lisboa 11-14 septiembre 2018.
  • Casado I, Martínez-Baz I, Navascués A, Pérez-García A, Aguinaga A, Floristán Y, et al. Detección de virus respiratorios en personas fallecidas durante la onda de gripe: un estudio piloto. [Respiratory virus detection in deceased persons: a pilot study]. XXXVI Reunión científica de la SEE, Lisboa 11-14 septiembre 2018.
  • Emborg HD, Hansen JV, Baum U, Martínez-Baz I, Castilla J, and the I-MOVE+ influenza group. Duration of seasonal influenza vaccine effectiveness against inpatient influenza A(H1N1) and A(H3N2) in the elderly: results from register-based European cohort studies conducted in 2015/16 and 2016/17. Nordic Vaccine Meeting, Helsinki, Finland, 14-15 June 2018.
  • Baum U, Emborg HD, Martínez-Baz I, Castilla J, and the I-MOVE+ influenza group. Combined effect of previous and current seasonal influenza vaccination on inpatient influenza A(H3N2) in the elderly: results from three European cohorte studies conducted in 2016/17. Nordic Vaccine Meeting, Helsinki, Finland, 14-15 June 2018.
  • Rose AMC, Rondy M, Gherasim A, Ezpeleta G, Alfonsi V, Launay O, et al. 2017–18 Vaccine effectiveness against influenza A(H3N2) and lineage mismatched influenza B in older adults: Results from the I-MOVE+ hospital network. ESCAIDE Conference, Malta, 20–23 November 2018.
  • Gherasim, F. Pozo, A. Larrauri, los grupos de trabajo cycEVA y IMOVE+.  Efecto de la vacunación previa y de la variación genética viral sobre la vacuna antigripal 2016-17 (Oral). XXXVI Reunión Anual de la Sociedad Española de Epidemiología (SEE) y XIII Congresso da Associação Portuguesa de Epidemiologia (APE), Lisboa, 11-14 septiembre 2018.
  • Gómez V, Kislaya I, Rodrigues AP, Costa I, Pechirra P, Cristóvão P, et al. Influenza Vaccine Effectiveness in the Portuguese elderly during 2017-18 season. XXXVI Reunião Anual da Sociedade Espanhola de Epidemiología (SEE) e XIII Congresso da Associação Portuguesa de Epidemiologia (APE), Lisboa, Portugal, 11-14 Setember 2018.
  • Sandmann F, Van Leeuwen E, de Boer P, Casado I, Castilla J, Domegan L, et al., On behalf of the I-MOVE+ Work Package 5 participants. Cost-effectiveness analysis of seasonal influenza vaccination strategies targeting children and/or the elderly  in 6 European countries and regions. ESCAIDE conference. Malta, 21-23 Novembro 2018.
  • Pechirra P, Borges V, Cristóvão P, Costa I, Conde P, Machado A, et al. Whole genome analysis of influenza A(H3) viruses detected between 2016-18 the scope of EuroEVA/I-MOVE vaccine effectiveness study. ESCAIDE conference. Malta, 21-23 November 2018.

Poster presentations

  • Gherasim A, Pozo F, Larrauri A, on behalf of cycEVA and IMOVE+ working groups. Previous vaccination and viral genetic variation effects over the 2016-17 influenza vaccine in Spain. ESCAIDE, Malta, 21-23 November 2018
  • Rodrigues AP, Kislaya I, Machado A, Gomez V, Bárbara C, Gonçalves P, et al. Role of influenza vaccine in pneumoccocal pneumonia using a screening method: a pilot study. XXXVI Reunião Anual da Sociedade Espanhola de Epidemiología (SEE) e XIII Congresso da Associação Portuguesa de Epidemiologia (APE), Lisboa, Portugal, 11-14 Setember 2018.
  • Kissling E, Pozo F, Buda S, Vilcu A, Alfonsi V, Larrauri A, et al. Influenza B vaccine effectiveness in the trivalent vaccine B/lineage-mismatched 2017/18 influenza season in Europe: investigating cross-protection and changes in VE over time. ESCAIDE, Malta, 21-23 November 2018
  • Kissling E, Pozo F, Buda S, Vilcu A, Alfonsi V, Larrauri A, et al. 2017/18 European influenza season: Disparate I-MOVE multicentre case control study estimates with A(H1N1), A(H3N2) and trivalent vaccine lineage-mismatched B/Yamagata influenza viruses circulating ESCAIDE, Malta, 21-23 November 2018